Depressive disorders in stroke patients.
Post-stroke depression is a serious complication of ischemic stroke which has negative influences on patients' quality of life and on recovery from symptoms and the prognosis of the underlying disease. We report here a study of the efficacy of treatment of patients with post-stroke depression with Opra, showing improvements in status in 93.3% of patients. Along with its antidepressant action, Opra had a marked anxiolytic effect. The agent had no adverse effects on the activities of daily living or cognitive functions, and produced minimal side effects.